Apollo launches India’s first AI-based oncology centre

The AI-POC provides oncology services focusing on patient-centric treatment and immunotherapy

(L-R)Uday Davada, Manish Mattoo, Vijay Agarwal, Vishwanath S, Suneeta Reddy, Dinesh Gundu Rao, Harshad Reddy, Dinesh Madhavan, Govindaiah Yatheesh, John Chandy / Image - Apollo Cancer Centers

In a momentous development, Bengaluru-based Apollo Cancer Centre has introduced India's first AI-Precision Oncology Centre (POC).

Using the vast potential of artificial intelligence (AI), the center will assist oncologists, patients, and caregivers in achieving the best outcomes in the quickest time. It will significantly improve the quality of oncology care in the country, a statement from the healthcare group said.

The AI-POC will also offer comprehensive medical services for oncology, with accurate diagnosis, real-time insights, cancer risk assessment, patient-centric treatment and immunotherapy.

Addressing the inauguration ceremony, Dinesh Gundu Rao, Karnataka State Minister for Health and Family Welfare, said, "This pioneering initiative not only represents a monumental leap in medical technology but it also symbolizes hope and progress for patients and caregivers. Apollo Hospitals' commitment to personalized oncology care through AI is a beacon of compassion and advancement, ensuring a brighter future for those battling cancer.”

Suneeta Reddy, managing director, Apollo Hospitals Enterprise, said, "The launch of AI -POC marks a significant stride in redefining cancer care. This transformative initiative is a testament to our unwavering commitment to personalized medicine and technological innovation. The POC reflects our dedication to providing patients with the most advanced, tailored treatments, underscoring Apollo Hospitals' relentless pursuit of excellence in healthcare delivery."

Dr Vijay Agarwal, lead and senior consultant – medical oncology, ACC, Bengaluru, underlined that the center will support new patient identification through auto-alerts to operational teams that identify eligible patients for POCs. “Patient SOS auto-alerts to operational teams on deteriorating patient outcomes for intervention and clinical escalation form another key feature,” he added.

Dr Vishwanath S, senior consultant, medical oncology, ACC, explained that the center will help in care pathway compliance by monitoring adherence to standard care pathways. “For patient management based on genomic, clinical, and pathological profiles. Clinical alerts and recommendations for diagnostic tests, enrollment for value-based Care & other patient benefit programs are some of the uses,” he added.